CTOs on the Move

Healthcare Partners Investments

www.hpillc.org

 
Healthcare Partners Investments is a Oklahoma City, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.hpillc.org
  • 14024 Quail Pointe Dr
    Oklahoma City, OK USA 73134
  • Phone: 405.419.8484

Executives

Name Title Contact Details

Similar Companies

Onarga Academy

An individualized, trauma-sensitive, and holistic approach to addressing boys` emotional and behavioral issues, and educational, recreational, and vocational goals.

Creative Community Living

Creative Community Living is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Winfield, KS. To find more information about Creative Community Living, please visit www.cclccl.org

Provation Medical

Provation is a leading provider of clinical productivity software for healthcare professionals, with solutions for intelligent procedure documentation (Provation® MD and Provation® Apex), order set and care plan management (Provation® Order Sets and Provation® Care Plans), and EHR-embedded clinical documentation templates (Provation® Clinic Note). Our software helps providers increase operational efficiencies, business profitability and regulatory compliance by improving quality, streamlining workflows and enabling the generation of insights. Trusted by leading physicians globally, we serve approximately 1,500 hospitals and 1,000 ambulatory surgery centers (ASCs), including 16 of the top 20 U.S. hospitals for gastroenterology (GI) and GI surgery. Provation is headquartered in Minneapolis, MN and is owned by Clearlake Capital Group, L.P.

Florida Cardiology, PA

Florida Cardiology, PA is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Winter Park, FL. To find more information about Florida Cardiology, PA, please visit www.flcard.com

CSL Behring

CSL Behring is a biopharmaceutical company, manufacturing plasma-derived and recombinant therapeutic products and providing them to people in more than 100 countries.